Procurement Summary
Country : Brazil
Summary : Deslanosideo 0.2 Mg/ml Injectable Solution Ampoule 2 Ml, Citarabine (cli) 500 Mg Sol Injectable Sol Bottle, B1/b2/b12/b12/pantotenato) Sol or Fr 100 Ml, Letrozol 2.5 Mg Compressed, Risperid ...
Deadline : 03 Nov 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 73903482
Document Ref. No. : 971/22
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
DESLANOSIDEO 0.2 mg/ml Injectable solution Ampoule 2 ml, citarabine (CLI) 500 mg Sol Injectable Sol Bottle, B1/B2/B12/B12/Pantotenato) Sol or FR 100 ml, Letrozol 2.5 mg Compressed, Risperidone 1 mg/ml oral solution 30 ml bottle., Almond oil sweet use topic 100 ml bottle, levodopa 100mg + benserazid (hydrochloride) 25mg with Disp, Ambriscentan 5 mg compressed
Expected execution deadline: 365 Days
Session Opening: 11/03/2022 Time: 0900 AM
Composition of items:
Sequence - Summary Description - Unit of Measurement - Quantity
1 - DESLANOSIDEO 0.2 mg/ml Injectable solution Ampoule 2 ml 11030081 108570 - UND - 3544
2 - CITARABINE (Hydrochloride) 500 mg Injectable Solution Vial - UND - 240
3 - Each 10 ml should contain vitamin B1 (thiamine hydrochloride) 30 mg vitamin B2 (riboflavin sodio phosphate) 10 mg vitamin B6 (pyodoxin hydrochloride) 10 mg, vitamin B12 (cyanocobalamine) 15 mcg, calcium pantotenato 15mg solution ORAL BOTTLE 100ML 11010068 472581 - ML - 39000
4 - LETROZOL 2.5 mg tablet 11080111 1020137 - UND - 4516
5 - Risperidone 1 mg/ml Oral Solution 30 ml. 11100091 2189003 - Vial 30 ml - 692
...
Documents
Tender Notice